Medications for Older Persons
Recommendations, Harms, Evidence
Paperback Engels 2025 9780443290251Samenvatting
Medications for Older Persons: Recommendations, Harms, Evidence provides a comprehensive resource detailing the benefits of medications for older individuals. It also addresses the potential harms associated with the prescription of potentially inappropriate medications or omissions in prescribing and examines how many adverse events, rehospitalizations, and deaths can be attributed to these medications. The book opens with a summary of medications that most benefit older patients, followed by the impact of older persons’ alcohol consumption, self-medication, and medication list accuracy and how these factors correlate to health outcomes.
The remainder of the book is devoted to the assessment of medication groups focusing on Numbers Needed to Treat, Numbers Needed to Harm, and characteristics and numbers of adverse events. Medication groups covered include cardiovascular, central nervous system, renal, gastrointestinal, musculoskeletal, respiratory, endocrine, pain, and fall prevention.
Specificaties
Lezersrecensies
Inhoudsopgave
1. A summary of medications that most benefit older patients: for clinicians, patients, their families, policy makers and health ministries
2. STOPP and American Geriatrics Society “potentially inappropriate medications" (PIMs) and START ”potential prescribing omissions” (PPOs)
3. The Calgary study of 295,706 admissions of older persons to four acute care hospitals 2013-2021
4. Adverse drug interactions in the Veterans Affairs Adverse Drug Event Reporting System
5. Pharmacokinetics and pharmacodynamics in older persons
6. Methods to identify adverse drug interactions and effects
7. How personalized medicine has changed senior patient outcomes at the Mayo Clinic and other centers
Section 2. Older persons alcohol consumption, self-medication, and medication list accuracy
8. Older persons alcohol consumption
9. Self-medication and over the counter medications by older persons
10. The accuracy of recording medication lists, transferring lists between community practitioners and medical institutions, and the potential effects on the accuracy of assessing PIMs, PPOs and adverse medication events
Section 3. Cardiovascular medications
11. Medications for hypertension
12. Medications for heart failure
13. Medications for arrhythmias
14. Medications for diuresis
15. Medications for coagulation
Section 4. Central Nervous System medications
16. Medications for depression
17. Medications for anxiety
18. Medications for insomnia
19. Neuroleptic/antipsychotic medications
20. Avoiding medications with risks of delirium
21. Avoiding medications that augment dementia
Section 5. Renal medication
22. Prescribing to reduce risks of renal insufficiency and failure
Section 6. Gastrointestinal medications
23. Prescribing to reduce the risks of peptic ulcer disease, gastritis, and esophagitis and treat if present
24. Prescribing to reduce the risks of constipation or diarrhea
Section 7. Musculoskeletal medications
25. Medications for arthritis
26. Medications for osteoporosis
Section 8. Respiratory medications
27. Medications for COPD
Section 9. Endocrine medications
28. Medications for diabetes
Section 10. Pain medications
29. Non-opioid analgesics and opioids for seniors
Section 11. Changing prescribing to prevent falls
30. Prescribing to prevent falls
Rubrieken
- advisering
- algemeen management
- coaching en trainen
- communicatie en media
- economie
- financieel management
- inkoop en logistiek
- internet en social media
- it-management / ict
- juridisch
- leiderschap
- marketing
- mens en maatschappij
- non-profit
- ondernemen
- organisatiekunde
- personal finance
- personeelsmanagement
- persoonlijke effectiviteit
- projectmanagement
- psychologie
- reclame en verkoop
- strategisch management
- verandermanagement
- werk en loopbaan